A product of purine and uric acid metabolism
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Allantoin

Item No. 30204

Technical Information
Formal Name
N-(2,5-dioxo-4-imidazolidinyl)-urea
CAS Number
97-59-6
Synonyms
  • (±)-Allantoin
  • NSC 7606
  • SD 101
  • 5-Ureidohydantoin
Molecular Formula
C4H6N4O3
Formula Weight
Purity
≥95%
A crystalline solid
DMSO: 1 mg/mlPBS (pH 7.2): 1 mg/ml
SMILES
O=C1[C@@H](NC(N)=O)NC(N1)=O
InChi Code
InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)/t1-/m0/s1
InChi Key
POJWUDADGALRAB-SFOWXEAESA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Allantoin is a product of purine and uric acid metabolism.1 It is formed through oxidation of uric acid by urate oxidase in most mammals but is formed only through non-enzymatic oxidation by free radicals in humans. Urinary levels of allantoin are increased prior to the onset of Alzheimer’s disease symptoms in mice expressing mutations in amyloid precursor protein and tau (APP/tau) but not during the early/middle stage of the disease, indicating its potential use as a biomarker for predicting Alzheimer’s disease onset.2 Due to the formation of allantoin by free radicals in humans, increased urinary levels are a potential biomarker for oxidative stress status.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Martinez-Moral, M.-P., and Kannan, K. Allantoin as a marker of oxidative stress: Inter- and intraindividal variability in urinary concentrations in healthy individuals. Environ. Sci. Technol. Lett. 6, 283-288 (2019).

    2. Fukuhara, K., Ohno, A., Ota, Y., et al. NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: Identification of oxidative stress biomarkers. J. Clin. Biochem. Nutr. 52(2), 133-138 (2013).